Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

An open-label extension study of the long-term safety and efficacy of rosiglitazone extended-release (RSG XR) in subjects with mild-to-moderate Alzheimer's disease (REFLECT-5)
rosiglitazone
AVA102677
NCT00550420
Alzheimer's Disease
Phase 3
 
This is a follow-up study to AVA105640.
May 2013

Powered by ideaPoint, Inc.